[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers]
- PMID: 16203265
[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers]
Abstract
Recent advances in proteomics offer opportunities to rapidly identify new biomarkers or pattern of markers for the early detection and diagnosis of cancer and to monitor the therapeutic efficacy and toxicity of treatments used to improve long-term survival of patients. The surfaced-enhanced laser desorption ionization/time-of-flight (Seldi-Tof) mass spectrometry is certainly one of the most promising approaches to achieve these goals. In this paper we will provide an overview of the studies that have used this new technology for the early diagnosis of human cancer.
Similar articles
-
Clinical proteomics and mass spectrometry profiling for cancer detection.Expert Rev Proteomics. 2006 Jun;3(3):311-20. doi: 10.1586/14789450.3.3.311. Expert Rev Proteomics. 2006. PMID: 16771703 Review.
-
Application of serum SELDI proteomic patterns in diagnosis of lung cancer.BMC Cancer. 2005 Jul 20;5:83. doi: 10.1186/1471-2407-5-83. BMC Cancer. 2005. PMID: 16029516 Free PMC article.
-
A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.Cancer Invest. 2006 Dec;24(8):747-53. doi: 10.1080/07357900601063873. Cancer Invest. 2006. PMID: 17162557
-
Clinical proteomics in breast cancer: a review.Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Breast Cancer Res Treat. 2009. PMID: 19082706 Review.
-
Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.Am J Clin Oncol. 2008 Apr;31(2):133-9. doi: 10.1097/COC.0b013e318145b98b. Am J Clin Oncol. 2008. PMID: 18391596
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources